FEOPS NV has a total of 18 patent applications. It increased the IP activity by 400.0%. Its first patent ever was published in 2013. It filed its patents most often in EPO (European Patent Office), United States and WIPO (World Intellectual Property Organization). Its main competitors in its focus markets medical technology and computer technology are MIT ENTW GMBH, EBM CORP and TORNIER INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 6 | |
#2 | United States | 6 | |
#3 | WIPO (World Intellectual Property Organization) | 4 | |
#4 | China | 2 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Computer technology |
# | Technology | |
---|---|---|
#1 | Diagnosis and surgery | |
#2 | Implantable devices | |
#3 | Healthcare informatics | |
#4 | Image data processing | |
#5 | Electric digital data processing |
# | Name | Total Patents |
---|---|---|
#1 | Mortier Peter Eddy J | 14 |
#2 | De Beule Matthieu Robert Anna Firmin | 14 |
#3 | De Santis Gianluca | 13 |
#4 | Debusschere Nic | 10 |
#5 | Dezutter Tim | 6 |
#6 | Astudillo Patricio Javier | 5 |
#7 | Iannaccone Francesco | 2 |
#8 | De Bock Sander | 2 |
#9 | Mortier Peter | 2 |
Publication | Filing date | Title |
---|---|---|
EP3706137A1 | Method and system for patient-specific predicting of cyclic loading failure of a cardiac implant | |
EP3542757A1 | Method and system for patient-specific virtual percutaneous structural heart intervention | |
EP3358482A1 | Method and system for determining a risk of hemodynamic compromise after cardiac intervention | |
WO2016177647A1 | Method and system for determining a risk of cardiac conduction abnormalities | |
US2015112659A1 | Pre-operative simulation of trans-catheter valve implantation |